EGFR and hepatocellular carcinoma: Lin et al. reported that the anti-EGFR drug resistance in HCC is caused by the promoted interaction of EGFR with mTORC2, this shows that the complex signaling pathways is the main reason of drug resistance in liver cancer cells [7].